Twist Bioscience Corporation
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-42.3M | $-74.3M | $32.0M | — |
| Jun 2022 | $-34.1M | $-74.8M | $40.6M | — |
| Dec 2022 | $-54.1M | $-65.9M | $11.8M | $-2.3M |
| Mar 2023 | $-44.3M | $-53.3M | $9.1M | — |
| Jun 2023 | $-23.4M | $-27.9M | $4.5M | — |
| Dec 2023 | $-23.0M | $-24.5M | $1.5M | $11.0M |
| Mar 2024 | $-19.4M | $-20.0M | $603.0K | — |
| Jun 2024 | $-6.4M | $-7.3M | $965.0K | — |
| Dec 2024 | $-21.4M | $-23.7M | $2.3M | $12.0M |
| Mar 2025 | $-13.0M | $-17.1M | $4.1M | — |
| Jun 2025 | $-1.4M | $-10.6M | $9.2M | — |
| Dec 2025 | $-24.8M | $-34.8M | $10.0M | $13.3M |
| Mar 2026 | $-17.6M | $-25.4M | $7.9M | — |
| Jun 2026 | $1.1M | $-8.6M | $9.8M | — |